Spurred by activism, educators are reworking curricula to train future generations to adapt to our changing climate

Preparations for storms include an emphasis on worker recovery

Stereo Chemistry explores how early-career chemists are confronting a changing climate

Nickel catalyst provides a route to the cleaning product chemicals with high yields and selectivity

The volatile compound replicates the aroma of hundreds of compounds in the real fruit

Guidelines include how to deal with pesky interfering signals when making voltammetric sensors

The industry's reliance on China-based firms for chemistry services is in the spotlight

Court documents allege the chemists made the drug and its precursors in a university laboratory

Biochemist's discovery of epidermal growth factors has led to new treatments for cancer and other diseases

The volatile compound replicates the aroma of hundreds of compounds in the real fruit

Nickel catalyst provides a route to the cleaning product chemicals with high yields and selectivity

Innovation, fast-paced change, and products that go down the drain give the sector its enduring appeal

Cheap feedstock from the US tempts chemical makers, but several hurdles stand in the way

A large number of diseases have been linked to the NLRP3 inflammasome. The race is on to develop drugs that disrupt it

P&G, Versalis, and Ineos look to novel technologies to confront plastic waste

Detailed models highlight a key role for solvents

Medical workers in China weigh the advantages and disadvantages of nucleic acid lab tests and CT lung scans

No, US EPA says in proposal

Venture will combine six active pharmaceutical ingredient production sites in Europe

Lower-temperature process improves the efficiency of single-crystal solar cells

Inaugural editor in chief will focus on emerging and interdisciplinary areas of environmental engineering

Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak

Biogen will pay the biotech firm $350 million upfront and get rights to its therapies for up to 12 neurological diseases

Results for 2019 show resilience, but coronavirus impact shadows forecasts for this year

Lower-temperature process improves the efficiency of single-crystal solar cells

The $4.9 billion deal adds a mid-stage cancer drug to the big biotech's pipeline

Single-crystal boron nitride could enable the use of 2-D materials for transistors in computer chips

Product launches and champagne toasts at instrumentation conference bely worries about infection

The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery

Ajay Mallia of Georgia Gwinnett College is named the national winner